Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07001423

ChOlecystectomy aFter successFul Endoscopic Common Bile Duct Stone Extraction in Elderly

The goal of this study is to compare safety and efficacy of laparoscopic cholecystectomy versus wait-and-see policy after endoscopic removal of common bile duct stones in elderly. The primary endpoint is a composite outcome: Death or major postoperative complications or recurrent biliary disease within 1 year after randomization.

Recruiting

Interested in participating?

Request Info

Key information

Age range

75 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Helsinki University Hospital, Jorvi, Espoo, Finland

Loading trial locations.

About this study

Elderly patients with common bile duct stones are asked to participate this randomized trial after successful endoscopic removal of common bile duct stones. The hypothesis of the study is that wait-and-see policy is non-inferior to laparoscopic cholecystectomy. Four hundred patients are randomized 1:1 to either laparoscopic cholecystectomy group or wait-and see group. Cholecystectomy is done on the same admission or within two weeks after randomization. One interim analysis is planned for the trial after 100 randomized patients to assess safety. The trial is terminated if there is a statistically significant difference in primary outcome with p<0.001 (chi-square test) between the study arms.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Common bile duct stones cleared after Endoscopic Retrograde Cholangio Pancreatography (ERCP)
  • Age >= 80 years or age 75-79 years with a Charlson Comorbidity index >=2
  • gallbladder in situ

Exclusion criteria

  • Acute Cholecystitis
  • Biliary Pancreatitis
  • Severe or moderately severe post-ERCP pancreatitis
  • Chronic pancreatitis
  • Bile duct pathology
  • Widespread malignancy
  • Unable to give consent

Treatment and study plan

Laparoscopic cholecystectomy

Procedure

Laparoscopic cholecystectomy within 2 weeks after endoscopic removal of common bile duct stone

Primary outcomes

  1. Number of participants with composite outcome of death, major complication or recurrent biliary event

    Time frame: From randomization to 1 year

    The primary outcome is a composite outcome including death within 1 year after randomization, the occurrence of major complications within 30 days from surgery and recurrent biliary event requiring hospitalization. within 1 year after randomization. A recurrent biliary event refers to cholecystitis, pancreatitis, cholangitis, or bile duct stones. Major complications were defined as infectious, cardiovascular and pulmonary complications, and surgical complication (Clavien-Dindo grade III or higher)

Secondary outcomes

  1. Number of good days

    Time frame: From randomization to 1 year

    Number of days alive and out of hospital

  2. EQ VAS value

    Time frame: at 30 days, 180 days and 365 days after randomization

    Quality of life is measured using EuroQOL EQ-5D-5L instrument, EQ VAS values are compared. 0 represents the worst health a person can imagine and 100 represents the the best health a person can imagine. EQ-5D-5L dimension responses are reported as a descriptive data

  3. Survival

    Time frame: From randomization to 1 year

    Survival is measured using Kaplan-Meier analysis

  4. Number of patients with major complications

    Time frame: From randomization to 1 year

    Number of patients with major complications defined as infectious, cardiovascular, and pulmonary complications, and surgical complication (Clavien-Dindo grade III or higher)

  5. Number of patients with recurrent biliary event

    Time frame: From randomization to 1 year

    Number of patients with recurrent biliary event (cholecystitis, pancreatitis, cholangitis, or symptomatic bile duct stones)

  6. Composite outcome of death or occurrence of major complications or recurrent biliary event requiring hospitalization

    Time frame: From randomization to 2 years

    The same as primary outcome, but after 2 years follow-up

  7. Number of patients with uncomplicated biliary pain or post cholecystectomy pain

    Time frame: At 30, 180 and 365 days after randomization

    Uncomplicated biliary pain/ post cholecystectomy pain. Specific 5 criteria of biliary pain include : 1. severe pain attacks, 2. lasting 15 to 30 minutes or longer, 3. location in epigastrium or right upper quadrant, 4. pain radiating to the back, 5. a positive pain response to simple analgesics

  8. Healthcare costs

    Time frame: From randomization to 1 year

    Healthcare costs related to bile stones; including laboratory tests, imaging (ultra sound, computer tomography, magnetic resonance imaging), procedures (Endoscopic Retrograde Cholangio Pancreatography (ERCP), laparoscopic cholecystectomy), emergency visits and hospital days.

Study contacts

Contact information is provided by the study sponsor or research team.

Panu Mentula, MD, PhD

CONTACT

[email protected]

+358504270183

Päivi Siironen, MD, PhD

CONTACT

[email protected]

+358504271343

Sponsors and collaborators

Lead sponsor

Helsinki University Central Hospital

Other

Registry information

Acronym: COFFEE

Important dates

Study start
2025
Primary completion
2031
Study completion
2032
First posted
Jun 3, 2025
Registry last updated
Oct 7, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.